| Prognostic significance of the metastasis-associated protein osteopontin in human breast cancer PS Rudland, A Platt-Higgins, M El-Tanani, S de Silva Rudland, ... Cancer research 62 (12), 3417-3427, 2002 | 430 | 2002 |
| Tuning in to RF MEMS GM Rebeiz, K Entesari, IC Reines, SJ Park, MA El-Tanani, A Grichener, ... IEEE microwave magazine 10 (6), 55-72, 2009 | 410 | 2009 |
| Two separate mechanisms for ligand-independent activation of the estrogen receptor MKK El-Tanani, CD Green Molecular Endocrinology 11 (7), 928-937, 1997 | 243 | 1997 |
| The regulation and role of osteopontin in malignant transformation and cancer MK El-Tanani, FC Campbell, V Kurisetty, D Jin, M McCann, PS Rudland Cytokine & growth factor reviews 17 (6), 463-474, 2006 | 231 | 2006 |
| Chemosensitization of cancer cells by siRNA using targeted nanogel delivery EB Dickerson, WH Blackburn, MH Smith, LB Kapa, LA Lyon, JF McDonald BMC cancer 10, 1-11, 2010 | 161 | 2010 |
| Ets gene PEA3 cooperates with β-catenin-Lef-1 and c-Jun in regulation of osteopontin transcription M El-Tanani, A Platt-Higgins, PS Rudland, FC Campbell Journal of Biological Chemistry 279 (20), 20794-20806, 2004 | 145 | 2004 |
| The yin and yang of vitamin D receptor (VDR) signaling in neoplastic progression: operational networks and tissue-specific growth control FC Campbell, H Xu, M El-Tanani, P Crowe, V Bingham Biochemical pharmacology 79 (1), 1-9, 2010 | 143 | 2010 |
| Corrugated microstrip coupled lines for constant absolute bandwidth tunable filters MA El-Tanani, GM Rebeiz IEEE Transactions on Microwave Theory and Techniques 58 (4), 956-963, 2010 | 139 | 2010 |
| High-performance 1.5–2.5-GHz RF-MEMS tunable filters for wireless applications MA El-Tanani, GM Rebeiz IEEE Transactions on Microwave Theory and Techniques 58 (6), 1629-1637, 2010 | 135 | 2010 |
| A flip-chip-packaged 25.3 dBm class-D outphasing power amplifier in 32 nm CMOS for WLAN application H Xu, Y Palaskas, A Ravi, M Sajadieh, MA El-Tanani, K Soumyanath IEEE Journal of Solid-State Circuits 46 (7), 1596-1605, 2011 | 115 | 2011 |
| A two-pole two-zero tunable filter with improved linearity MA El-Tanani, GM Rebeiz IEEE Transactions on Microwave Theory and Techniques 57 (4), 830-839, 2009 | 114 | 2009 |
| Role of osteopontin in cellular signaling and metastatic phenotype MK El-Tanani Front Biosci 13 (4), 276, 2008 | 108 | 2008 |
| Ran is a potential therapeutic target for cancer cells with molecular changes associated with activation of the PI3K/Akt/mTORC1 and Ras/MEK/ERK pathways HF Yuen, KK Chan, C Grills, JT Murray, A Platt-Higgins, OS Eldin, ... Clinical Cancer Research 18 (2), 380-391, 2012 | 107 | 2012 |
| Agelastatin A: a novel inhibitor of osteopontin-mediated adhesion, invasion, and colony formation CK Mason, S McFarlane, PG Johnston, P Crowe, PJ Erwin, MM Domostoj, ... Molecular cancer therapeutics 7 (3), 548-558, 2008 | 106 | 2008 |
| DJ-1 could predict worse prognosis in esophageal squamous cell carcinoma HF Yuen, YP Chan, S Law, G Srivastava, M El-Tanani, TW Mak, KW Chan Cancer Epidemiology Biomarkers & Prevention 17 (12), 3593-3602, 2008 | 101 | 2008 |
| Erythropoietin-induced activation of the JAK2/STAT5, PI3K/Akt, and Ras/ERK pathways promotes malignant cell behavior in a modified breast cancer cell line Z Shi, VM Hodges, EA Dunlop, MJ Percy, AP Maxwell, M El-Tanani, ... Molecular Cancer Research 8 (4), 615-626, 2010 | 95 | 2010 |
| Osteopontin as a target for cancer therapy NI Johnston, VK Gunasekharan, A Ravindranath, C O’Connell, ... Front Biosci 13 (4361), 72, 2008 | 91 | 2008 |
| Preparation and in vivo evaluation of insulin-loaded biodegradable nanoparticles prepared from diblock copolymers of PLGA and PEG Y Haggag, Y Abdel-Wahab, O Ojo, M Osman, S El-Gizawy, M El-Tanani, ... International journal of pharmaceutics 499 (1-2), 236-246, 2016 | 85 | 2016 |
| Interaction between estradiol and growth factors in the regulation of specific gene expression in MCF-7 human breast cancer cells MKK El-Tanani, CD Green The Journal of steroid biochemistry and molecular biology 60 (5-6), 269-276, 1997 | 85 | 1997 |
| Targeting HOX/PBX dimers in cancer R Morgan, M El-Tanani, KD Hunter, KJ Harrington, HS Pandha Oncotarget 8 (19), 32322, 2017 | 82 | 2017 |
Dr Murtaza TambuwalaAssociate Professor in Pharmacology and Therapeutics, University of Lincoln在 lincoln.ac.uk 的电子邮件经过验证
